Matches 1 - 33 out of 33


Match Document Document Title
US20130189343 Transmucosal administration system for a pharmaceutical drug  
The present invention relates to a transmucosal administration system to administer quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route.
US20130136784 METHODS FOR DELIVERY OF MEDICATION USING DISSOLVABLE DEVICES  
A method utilizing a dissolvable device for the internal delivery of medication and more particularly to the use of fibers or non-woven fabrics made of a safe polymer material incorporating a...
US20120015021 ANTI-APPETITE ADHESIVE COMPOSITIONS  
Compositions for appetite suppression and methods of making and using thereof are disclosed herein. The compositions are typically in the form of a tablet, such as a single or multi-layer sticker...
US20130156842 BIOADHESIVE DRUG FORMULATIONS FOR ORAL TRANSMUCOSAL DELIVERY  
Bioadhesive drug formulations that adhere to an oral mucosal membrane of a subject are provided together with single dose applicators and devices for delivering the drug formulations to the oral...
US20100285098 ADHERING TROCHES WITH SANTACID FOR TREATMENT OF THROAT ESOPHAGUS AND STOMACH  
A method for combating unwanted conditions downstream of the mouth with adhering troches. A method to treat or reduce replication of a virus in throat tissues by releasing an anti-viral from an...
US20100092543 Dimpled adhering troche for use on teeth or orthodontic braces  
A dissolving oral adhering disc with a dimple on at least one side to improve adhesion to hard convex surfaces in the mouth, including teeth, orthodontic braces, and gums (keratinized gingiva)....
US20090148500 MEDICINAL IMPLANT CARTRIDGE  
The invention includes a cartridge for use in a device for inserting a medicament within a body cavity of a mammal, the cartridge including a housing, a retractable chamber disposed within the...
US20080020018 Combination Products  
A pharmaceutical formulation comprises a plurality of seamless minicapsules having a diameter of from 0.5 mm to 5 mm, at least some of the minicapsules containing a methyxanthine as one active...
US20090291118 UNIVERSAL BARRIER TO PREVENT INFECTIONS FROM HUMAN IMMUNODEFICIENCY VIRUS  
The Human Immunodeficiency Virus poses a significant threat to the world's population. Current strategies to treat infectious agents have not been adequate to eradicate such deadly viral...
US20090175925 PASSIVE TIME RELEASED SOLUTE TREATMENT  
Devices and methods for delivery of a solute to increase blood sugar levels between certain hours in a form that allows for gradual delivery. One variation includes devices and methods for the...
US20150056268 UNIFORM FILMS FOR RAPID-DISSOLVE DOSAGE FORM INCORPORATING ANTI-TACKING COMPOSITIONS  
The present invention relates to water-soluble films incorporating anti-tacking agents and methods of their preparation. Anti-tacking agents may improve the flow characteristics of the...
US20100158854 METHOD FOR TREATMENT OF AIRWAY AND APPARATUS AND KIT FOR USE THEREWITH  
A method of treating an airway in a mammalian body having a mouth, soft palate, uvula, throat and tongue. An implant-forming material is introduced into at least one of the soft palate and uvula...
US20090130177 DENTAL IMPLANT AND PRODUCTION METHOD FOR SAID IMPLANT  
The invention relates to a dental implant, which comprises a coating at least in those surface areas that come into contact with hard and/or soft tissue when implanted. To ensure that the active...
US20130323296 CARRIER FOR OROMUCOSAL, ESPECIALLY SUBLINGUAL ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE SUBSTANCES  
The present disclosure relates to a carrier for oromucosal, especially sublingual administration of physiologically active substances, especially of medicinal drugs, which consists of at least one...
US20140271781 HYDROGEL COMPOSITIONS WITH AN ERODIBLE BACKING MEMBER  
A composition is provided, wherein the composition comprises a water-swellable, water-insoluble polymer, a blend of a hydrophilic polymer with a complementary oligomer capable of hydrogen or...
US20080187573 PHARMACEUTICAL COMPOSITION FORMULATED FOR PRE-GASTRIC ABSORPTION OF MONOAMINE OXIDASE B INHIBITOR COMPONENT  
A fast dispersing solid pharmaceutical composition having a monoamine oxidase B inhibitor as the only active ingredient is disclosed for the treatment of Parkinson's disease. The composition is...
US20090304776 TRANSMUCOSAL DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE THEREOF  
Described herein is a transmucosal delivery device and their use for delivering bioactive agents across a mucosal membrane. The delivery devices contain a pharmaceutically acceptable oxidizing and...
US20090324692 Polyurethane Elastomers  
A linear polymer is obtained by reacting together a polyethylene glycol or polypropylene glycol; a PEG-PPG-PEG or PPG-PEG-PPG block copolymer; a difunctional amine or diol; and a diisocyanate. A...
US20090291120 Hydrophilic Polyurethane Compositions  
A water-swellable linear polymer is made by reacting together a polyethylene oxide of number average molecular weight less than 4,000, an aliphatic diol, and a difunctional diisocyanate....
US20100203105 METHOD FOR ADMINISTERING INSULIN TO THE BUCCAL REGION  
A mixed micellar pharmaceutical formulation includes a micellar pharmaceutical agent, an alkali metal C8 to C22 alkyl sulfate, alkali metal salicylate, a pharmaceutically acceptable edetate and at...
US20080160065 DRUG DELIVERY POLYMER WITH HYDROCHLORIDE SALT OF CLINDAMYCIN  
One embodiment provides an insert, which includes a non-degradable hydrogel matrix and clindamycin hydrochloride in contact with the matrix, wherein the insert is suitable for mammalian...
US20090028924 USE OF A POLYSACCHARIDE WHICH IS EXCRETED BY THE VIBRIO DIABOLICUS SPECIES FOR THE REGENERATION AND PROTECTION OF THE PERIODONTIUM  
The invention relates to the use of a polysaccharide which is excreted by the Vibrio diabolicus species for the re-generation and protection of the non-mineralised connective tissue of the...
US20080233174 HIGH DOSE FILM COMPOSITIONS AND METHODS OF PREPARATION  
This invention relates to films incorporating high amounts of pharmaceutical agents and methods for the preparation of the same. Moreover, the invention relates to the film products and methods of...
US20100172956 DISSOLVING STRIP FOR ORAL MUCOSA AS A SYSTEMIC DRUG DELIVERY ROUTE  
The invention relates to a dissolving strip for drug delivery providing a generally inert water soluble base material attached to the maxillary molars in order to deliver a therapeutic material...
US20070292479 Film-shaped drug forms for use in the oral cavity (wafers)  
The present invention describes film-shaped systems capable of transmucosal buccal application and comprising at least one steroid hormone from the group of the androgens, the progestogens and the...
US20100098746 COMPOSITIONS AND METHODS FOR TREATING PERIODONTAL DISEASE COMPRISING CLONIDINE, SULINDAC AND/OR FLUOCINOLONE  
Effective treatments of periodontal disease for extended periods of time are provided. Through the administration of an effective amount of clonidine, sulindac, and/or fluocinolone at or near a...
US20170165299 COMPOSITIONS AND METHODS RELATING TO TREATMENTS OF THE ORAL CAVITY  
The present invention relates to compositions and methods utilizing hair follicle derived Non-Bulbar Dermal Sheath cells for use in the treatment of dental-related conditions, including the...
US20170071986 Method and System for Targeting the Microbiome to Promote Health and Treat Inflammatory Diseases  
A method and system of reducing the likelihood of an inflammatory disease developing by providing a mucosal adhesive strip to a subject, with the strip provided with at least one of a plurality of...
US20160324768 TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE  
The present invention provides methods for enhancing transmucosal uptake of a medicament, e.g., fentanyl or buprenorphine, to a subject and related devices. The method includes administering to a...
US20160310409 TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE  
The present invention provides methods for enhancing transmucosal uptake of a medicament, e.g., fentanyl or buprenorphine, to a subject and related devices. The method includes administering to a...
US20160166737 COLLAGEN SPONGE  
A resilient resorbable chemically crosslinked collagen sponge for promoting soft tissue volume augmentation in the oral region, comprising 60-96% (w/w) collagen and 4-40% (w/w) elastin, which...
US20150366793 TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE  
The present invention provides methods for enhancing transmucosal uptake of a medicament, e.g., fentanyl or buprenorphine, to a subject and related devices. The method includes administering to a...
US20150290122 METHOD OF ORALLY ADMINISTERING A TREATING AGENT OVER AN EXTENDED PERIOD  
An implantation device for and method of orally administering a time released treating agent to a user over an extended period, including fixedly engaging at least one tooth of the user with the...

Matches 1 - 33 out of 33